Manchester Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Manchester Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,515	Closed	-$109K	–	837
2020 Q4	$109K	Hold	1,515	–	–	0.02%	306
2020 Q3	$69K	Hold	1,515	–	–	0.01%	315
2020 Q2	$68K	Hold	1,515	–	–	0.01%	339
2020 Q1	$58K	Hold	1,515	–	–	0.01%	341
2019 Q4	$70K	Buy	+1,515	New	+$65.6K	0.01%	339

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Manchester Capital Management's BEAT Position: Q1 2021 in Review

Manchester Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 1,515 shares — an estimated $109K sold.

Manchester Capital Management first reported a position in BEAT in Q4 2019 and held it in 5 quarters. The position peaked at $109K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Manchester Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Manchester Capital Management sold 1,515 BioTelemetry, Inc. shares in Q1 2021, an estimated $109K.
Manchester Capital Management first reported a position in BioTelemetry, Inc. in Q4 2019 and held it in 5 quarters.
Manchester Capital Management's BioTelemetry, Inc. position peaked at $109K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Manchester Capital Management's 13F filing for Q1 2021, filed 13 May 2021.